Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma

Intrahepatic cholangiocarcinoma is in most transplant regions a contraindication for liver transplantation, even ruling out an active waiting list registration. However, recent studies showed that well-selected patients after a neo-adjuvant treatment benefit from liver transplantation with good long...

Full description

Saved in:
Bibliographic Details
Published inCurrent oncology (Toronto) Vol. 29; no. 3; pp. 1932 - 1938
Main Authors Rauchfuß, Falk, Ali-Deeb, Aladdin, Rohland, Oliver, Dondorf, Felix, Ardelt, Michael, Settmacher, Utz
Format Journal Article
LanguageEnglish
Published Switzerland MDPI 13.03.2022
MDPI AG
Subjects
Bile Duct Neoplasms - surgery
Bile Ducts, Intrahepatic
Cholangiocarcinoma - etiology
Cholangiocarcinoma - surgery
hepatobiliary disease
Humans
Liver Transplantation - adverse effects
living donation
Living Donors
malignancy
transplant oncology
transplant oncology
malignancy
living donation
hepatobiliary disease
Online AccessGet full text

Cover

More Information
Summary:Intrahepatic cholangiocarcinoma is in most transplant regions a contraindication for liver transplantation, even ruling out an active waiting list registration. However, recent studies showed that well-selected patients after a neo-adjuvant treatment benefit from liver transplantation with good long-term outcomes. The role of living donor liver transplantation is unclear for this indication. The current study focuses on LDLT for intrahepatic cholangiocarcinoma.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1718-7729
1198-0052
1718-7729
DOI:10.3390/curroncol29030157